Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.740
+0.130 (4.98%)
At close: Dec 19, 2025, 4:00 PM EST
2.610
-0.130 (-4.74%)
After-hours: Dec 19, 2025, 7:23 PM EST
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $4.11 million as of December 19, 2025. Its market cap has decreased by -24.96% in one year.
Market Cap
4.11M
Enterprise Value
641.46K
1-Year Change
-24.96%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $4.11M, a decrease of -84.29%. That is a compound annual growth rate of -34.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.11M | -32.06% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |